Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Severe cutaneous reaction during radiation therapy with concurrent cetuximab.

Literature DB >> 17671265

Severe cutaneous reaction during radiation therapy with concurrent cetuximab.

Wilfried Budach, Edwin Bölke, Bernhard Homey.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2007 PMID： 17671265 DOI： 10.1056/NEJMc071075

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

35 in total

1. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.

Authors: K Kian Ang; Qiang Zhang; David I Rosenthal; Phuc Felix Nguyen-Tan; Eric J Sherman; Randal S Weber; James M Galvin; James A Bonner; Jonathan Harris; Adel K El-Naggar; Maura L Gillison; Richard C Jordan; Andre A Konski; Wade L Thorstad; Andy Trotti; Jonathan J Beitler; Adam S Garden; William J Spanos; Sue S Yom; Rita S Axelrod
Journal: J Clin Oncol Date: 2014-09-20 Impact factor: 44.544

Review 2. [Therapy with epidermal growth factor receptor inhibitors. Clinical spectrum of cutaneous adverse effects].

Authors: P A Gerber; B A Buhren; S Kürle; B Homey
Journal: Hautarzt Date: 2010-08 Impact factor: 0.751

3. Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas.

Authors: Antonin Levy; Pierre Blanchard; Sara Bellefqih; Nacéra Brahimi; Joël Guigay; François Janot; Stéphane Temam; Jean Bourhis; Eric Deutsch; Nicolas Daly-Schveitzer; Yungan Tao
Journal: Strahlenther Onkol Date: 2014-03-18 Impact factor: 3.621

4. Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients.

Authors: Peter Arne Gerber; Stephan Meller; Tatiana Eames; Bettina Alexandra Buhren; Holger Schrumpf; Sonja Hetzer; Laura Maximiliane Ehmann; Wilfried Budach; Edwin Bölke; Christiane Matuschek; Andreas Wollenberg; Bernhard Homey
Journal: Eur J Med Res Date: 2012-02-23 Impact factor: 2.175

Severe cutaneous reaction during radiation therapy with concurrent cetuximab.

1. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.

Review 2. [Therapy with epidermal growth factor receptor inhibitors. Clinical spectrum of cutaneous adverse effects].

3. Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas.

4. Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients.

5. Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial.

Review 6. [Cutaneous side effects of targeted cancer drugs].

7. [Individualized, personalized and stratified medicine: a challenge for allergology in ENT?].

Review 8. The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck.

Review 9. Skin toxicities associated with epidermal growth factor receptor inhibitors.

Review 10. Current aspects of targeted therapy in head and neck tumors.